Literature DB >> 12234852

DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.

Kenji Hirose1, Ai Hashimoto, Kazumichi Tamura, Yoshiaki Kawamura, Takayuki Ezaki, Hiroko Sagara, Haruo Watanabe.   

Abstract

The mutations that are responsible for fluoroquinolone resistance in the gyrA, gyrB, parC, and parE genes of Salmonella enterica serovar Typhi and serovar Paratyphi A were investigated. The sequences of the quinolone resistance-determining region of the gyrA gene in clinical isolates which showed decreased susceptibilities to fluoroquinolones had a single mutation at either the Ser-83 or the Asp-87 codon, and no mutations were found in the gyrB, parC, and parE genes.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12234852      PMCID： PMC128770          DOI： 10.1128/AAC.46.10.3249-3252.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A.

Authors:  E J Threlfall; J A Skinner; L R Ward
Journal:  J Antimicrob Chemother       Date:  2001-11       Impact factor: 5.790

2.  gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.

Authors:  S Nakamura; M Nakamura; T Kojima; H Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  Treatment of multiresistant typhoid fever.

Authors:  B Rowe; L R Ward; E J Threlfall
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

4.  New topoisomerase essential for chromosome segregation in E. coli.

Authors:  J Kato; Y Nishimura; R Imamura; H Niki; S Hiraga; H Suzuki
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

5.  Treatment of multiresistant Salmonella typhi with oral ciprofloxacin.

Authors:  S J Eykyn; H Williams
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

6.  A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.

Authors:  S J Olsen; E E DeBess; T E McGivern; N Marano; T Eby; S Mauvais; V K Balan; G Zirnstein; P R Cieslak; F J Angulo
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

7.  Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.

Authors:  E Giraud; A Brisabois; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

8.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

9.  Treatment of typhoid fever with ofloxacin.

Authors:  F Wang; X J Gu; M F Zhang; T Y Tai
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

10.  Quinolone-resistant mutations of the gyrA gene of Escherichia coli.

Authors:  H Yoshida; T Kojima; J Yamagishi; S Nakamura
Journal:  Mol Gen Genet       Date:  1988-01
View more
  26 in total

1.  Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype Typhi.

Authors:  A Tatavarthy; R Sanderson; K Peak; G Scilabro; P Davenhill; A Cannons; P Amuso
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

2.  Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.

Authors:  Dilruba Ahmed; Liton T D'Costa; Khorshed Alam; G Balakrish Nair; M Anowar Hossain
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  GyrA ser83 and ParC trp106 Mutations in Salmonella enterica Serovar Typhi Isolated from Typhoid Fever Patients in Tertiary Care Hospital.

Authors:  Muthu Gopal; Sathishkumar Elumalai; Suresh Arumugam; Vishnuprabu Durairajpandian; Munirajan Arasambattu Kannan; Esthermary Selvam; Srivani Seetharaman
Journal:  J Clin Diagn Res       Date:  2016-07-01

4.  Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones.

Authors:  Kenji Hirose; Jun Terajima; Hidemasa Izumiya; Kazumichi Tamura; Eiji Arakawa; Nobuko Takai; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.

Authors:  Sheng Chen; Shenghui Cui; Patrick F McDermott; Shaohua Zhao; David G White; Ian Paulsen; Jianghong Meng
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

6.  Characterization of multidrug-resistant typhoid outbreaks in Kenya.

Authors:  Samuel Kariuki; Gunturu Revathi; Jane Muyodi; Joyce Mwituria; Agnes Munyalo; Sajjad Mirza; C Anthony Hart
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Quinolone and cephalosporin resistance in enteric Fever.

Authors:  Malini Rajinder Capoor; Deepthi Nair
Journal:  J Glob Infect Dis       Date:  2010-09

8.  Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.

Authors:  J M Ling; E W Chan; A W Lam; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

9.  Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion.

Authors:  Hadas Solnik-Isaac; Miriam Weinberger; Mina Tabak; Alon Ben-David; Dina Shachar; Sima Yaron
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

10.  Clonal expansion and microevolution of quinolone-resistant Salmonella enterica serotype typhi in Vietnam from 1996 to 2004.

Authors:  Thi Anh Hong Le; Laëtitia Fabre; Philippe Roumagnac; Patrick A D Grimont; Maurice R Scavizzi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.